Cargando…
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction
BACKGROUND: We evaluated vortioxetine’s effects on functional capacity in demographic and clinical subgroups of patients with major depressive disorder. METHODS: This was an exploratory analysis of the CONNECT study (NCT01564862) that evaluated changes in functional capacity using University of Cali...
Autores principales: | Keefe, Richard S E, Nomikos, George, Zhong, Wei, Christensen, Michael Cronquist, Jacobson, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932468/ https://www.ncbi.nlm.nih.gov/pubmed/29546401 http://dx.doi.org/10.1093/ijnp/pyy020 |
Ejemplares similares
-
PS83. Impact of Vortioxetine on Functional Capacity in MDD Patients with Subjective Cognitive Dysfunction: A Post-hoc Analysis of the University of California San Diego Performance-Based Skills Assessment
por: Jacobson, William, et al.
Publicado: (2016) -
PS80. Utilization of Baseline Patient Characteristics to Evaluate the Psychometric Properties the UCSD Performance-Based Skills Assessment (UPSA) and Determine Clinically Relevant Treatment Response in 600 Patients with Major Depressive Disorder
por: Harvey, Philip D., et al.
Publicado: (2016) -
Efficacy of vortioxetine on the physical symptoms of major depressive
disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018) -
Effectiveness of vortioxetine in patients with major depressive
disorder and co-morbid generalized anxiety disorder in routine clinical
practice: A subgroup analysis of the RELIEVE study
por: Almeida, Susana S, et al.
Publicado: (2022) -
Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
por: Christensen, Michael Cronquist, et al.
Publicado: (2022)